The UK is the first country to allow OTC access to Sanofi's tadalafil-based erectile dysfunction drug Cialis following a successful switch. Approved as a pharmacy medicine, Sanofi will launch Cialis Together in the second half of the year. Cialis will compete against Viatris' sildenafil-based Viagra Connect in the men's sexual health and wellness category, which has seen a proliferation of products in recent months.
The UK has become the first market to offer an OTC version of Sanofi’s tadalafil-based erectile dysfunction treatment Cialis.
Following advice from UK’s independent Commission on Human Medicines, the Medicines and Healthcare products Regulatory Agency has decided to make...